Red Clover

What is Red Clover?

Red clover is a flowering perennial herb native to Europe, Western Asia, and northwest Africa, now widely naturalized worldwide. Its aerial parts—particularly the flowers—contain four primary isoflavones: formononetin, biochanin A, daidzein, and genistein, which are converted by gut bacteria into active metabolites that interact with estrogen receptors. Standardized extracts (most commonly 40–160 mg isoflavones/day) have been the subject of multiple clinical trials, primarily in menopausal women.

How does Red Clover work?

Red clover isoflavones act as selective estrogen receptor modulators (SERMs), binding preferentially to estrogen receptor beta (ERβ) over ERα, which gives them tissue-selective estrogenic and anti-estrogenic effects. In the hypothalamus and thermoregulatory centers, mild estrogenic activity is thought to blunt the neuronal dysregulation responsible for vasomotor symptoms such as hot flashes. Isoflavones also influence lipid metabolism, endothelial nitric oxide production, and osteoblast/osteoclast activity, which underlies their proposed cardiovascular and bone-protective effects.

What forms does Red Clover come in?

Standardized isoflavone tablets (40–160 mg/day) are the forms used in published clinical trials and offer the most reliable dosing. The proprietary extract Promensil (40–80 mg isoflavones) has the largest body of trial evidence. Tinctures and teas provide variable isoflavone concentrations and are less reliably studied. Topical creams exist but have minimal clinical evidence for systemic effects.

Where it comes from:

Red clover has been used in traditional European and Native American herbalism for respiratory conditions, skin disorders, and as a 'blood purifier.' Interest in its phytoestrogenic properties was sparked by observations in the 1940s–1950s of reproductive abnormalities in sheep grazing on red clover-heavy pastures ('clover disease'), which prompted investigation of its isoflavone content and eventual human clinical trials beginning in the 1990s.

What does Red Clover help with?

Red clover is a flowering plant from the pea family. Its flowers and leaves hold compounds called isoflavones. These plant compounds act a little like the body's own estrogen, but much more weakly.

• Hot flashes during menopause
  Good evidence — a 2007 Cochrane review of several randomised trials, plus repeated trials of a branded extract. A 2007 review by Lethaby and colleagues, in the Cochrane Database of Systematic Reviews, pooled trials of plant estrogens. Red clover isoflavones lowered how often hot flashes came, more than placebo, but the drop was modest. Trials mostly used Promensil at 40 to 80 mg a day, and women with the most hot flashes at the start gained the most.
  Evidence grade B · Traditional tier T2
• Bone thinning in the spine
  Good evidence — one year-long randomised trial in 205 women. Atkinson and colleagues (2004, European Journal of Clinical Nutrition) followed 205 women who had not yet reached menopause. They took 26 mg or 50 mg of red clover isoflavones a day for one year. Bone loss in the lower spine was slower than in the placebo group.
  Evidence grade B · Traditional tier T2
• Anxiety and low mood around menopause
  Early evidence — one small 30-person randomised trial. van de Weijer and Barentsen (2002, Maturitas) gave 80 mg a day of red clover isoflavones to 30 women. Over 12 weeks, anxiety scores dropped and well-being scores rose more than with placebo. The trial was small, and no large trial has repeated it.
  Evidence grade C · Traditional tier T2
• Stiff arteries and heart risk markers
  Early evidence — one 17-person randomised trial, with mixed results across other small trials. Nestel and colleagues (1999, Journal of Clinical Endocrinology and Metabolism) gave 40 mg a day to 17 women past menopause. Their arteries became more elastic than in the placebo group. Across other small and medium trials, changes in LDL and HDL cholesterol did not line up.
  Evidence grade C · Traditional tier T2

What Red Clover has not been shown to do

• It has not been shown to cut heart attacks, strokes or deaths, because no large trial has tested those outcomes.
• It has not been shown to change LDL or HDL cholesterol in a steady, repeatable way.
• It has not been shown to slow bone loss in women past menopause as clearly as in younger women.
• It has not been shown to match standard hormone therapy for hot flashes; the effects seen were smaller.

How to read this:

Each use gets its own grade, based on the studies behind that use alone. A means many matching human trials. B means at least one good human trial. C means small or early human work. D means the human evidence is weak or clashes. Insufficient means no human study at all. This page reports what studies found. It is not a promise of results, not medical advice, and not a reason to stop any prescribed treatment. Talk with your own clinician before you start.

What can Red Clover help prevent?

• Accelerated bone mineral density loss in perimenopausal women (supported by RCT evidence, though effect size is modest)

What are the side effects of Red Clover?

• Mild gastrointestinal upset (nausea, bloating, diarrhea): most commonly reported adverse effect in trials
• Headache: reported at low frequency in several RCTs
• Breast tenderness: rare, related to estrogenic activity
• Spotting or menstrual irregularity: rare; case reports in premenopausal women
• Skin rash: rare hypersensitivity reaction
• Theoretical endometrial stimulation with very high long-term doses — not well characterized in clinical data
• Potential inhibition of thyroid hormone synthesis at very high isoflavone intakes — theoretical, not confirmed at typical supplemental doses in humans

Good to know:

Red clover isoflavones at doses used in clinical trials (40–160 mg/day) have a generally favorable short-term safety profile. Most RCTs of up to 12 months have not found significant adverse events versus placebo. Long-term safety beyond 2 years has not been rigorously established, and safety in women with hormone-sensitive conditions (estrogen receptor-positive breast cancer, uterine fibroids, endometriosis) is not confirmed.

How much Red Clover should you take?

• Recommended daily: 40–160 mg/day of standardized red clover isoflavones; most clinical trials used 40–80 mg/day (e.g., Promensil 40 mg or 80 mg tablet). For menopausal hot flashes, 80 mg/day is the most commonly studied effective dose.
• Best time of day: No strong evidence specifying optimal timing; taking with a meal may improve tolerability and is consistent with most trial protocols.
• With or without food: Preferably with food to reduce gastrointestinal side effects and because isoflavone absorption may be modestly improved in the presence of food.
• Time to effect: Vasomotor symptom improvement typically begins at 4 weeks and is more reliably measurable at 8–12 weeks of consistent daily use.
• How long to take it: Most published trials ran 12–24 weeks; long-term use beyond 12 months has not been systematically evaluated for safety. Women should reassess need annually with their healthcare provider. No formal cycling protocol is established, but periodic breaks (e.g., 3–6 month reassessment) are a reasonable precautionary approach.